1098819

Supernus Pharmaceuticals, Inc. — FEI 3005209462

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)